Thomas Shannon
Signal active
President and CEO
Bio
Tom Shannon is President and CEO of BrightStar. He was board chairman and a lead investor in Proxim Diagnostics Corp., Somna Therapeutics LLC, and Aver Informatics Inc. and CEO of biotech company Prodesse Inc. Tom has also served as a director of the Wisconsin Angel Network, Promentis Pharmaceuticals Inc., Stemina Biomarker Discovery Inc. and OKANJO Partners Inc. He has earned the CFP credentials and is an inductee into the Wisconsin Investor hall of fame.
Location
Saukville, Wisconsin, United States, North America
Social
Primary Organization
BrightStar Wisconsin Foundation
Founded
2013
Investment
59
Lead investment
15
Exits
7
Employees
11-50
Industry
Venture Capital
Jobs history
0
N/A
Board and Advisor Roles
0
N/A
Invest in regions
Profile Resume
Thomas Shannon is the President and CEO at BrightStar Wisconsin Foundation, based in United States, North America. With a background in Venture Capital, Thomas Shannon has a rich history of leadership and innovation. Explore their detailed professional journey, key connections, and contributions to the industry on our platform.
Recommendation from your interest
N/A
Jeff Rusinow
No designation
Andrew Shannon
No designation
Jeffery Harris
Board Member
Investment portfolio
Thomas Shannon has made 3 investments. Their Latest investment was Seed Round - Somna Therapeutics on May 02, 2012
Number of investment
3
Number of exits
2
Personal investment
3
| Annouced Date | Organization Name | Funding Round | Money Raised |
|---|---|---|---|
| Jan 01, 2002 | Prodesse | Seed Round - Prodesse | 1.5M |
| Oct 13, 2011 | HarQen | Series B - HarQen | 4.3M |
| May 02, 2012 | Somna Therapeutics | Seed Round - Somna Therapeutics | 1.1M |
Prodesse
HarQen
Somna TherapeuticsPartner investment
0
There is no partner investment available on this profile
Invest in industries
Recent Activity
There is no recent news or activity for this profile.